212 related articles for article (PubMed ID: 32646896)
1. Adding an important piece to the pulmonary vascular resistance puzzle in pulmonary arterial hypertension.
Maron BA; Humbert M
Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32646896
[No Abstract] [Full Text] [Related]
2. Clinical application of pulmonary vascular resistance in patients with pulmonary arterial hypertension.
Deng J
J Cardiothorac Surg; 2021 Oct; 16(1):311. PubMed ID: 34670595
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
Weatherald J; Boucly A; Savale L; Jaïs X; Montani D; Humbert M; Sitbon O
Am J Respir Crit Care Med; 2021 Feb; 203(4):524-525. PubMed ID: 33105080
[No Abstract] [Full Text] [Related]
4. Reply to Weatherald
Badagliacca R; D'Alto M; Ghio S; Vizza CD; Naeije R
Am J Respir Crit Care Med; 2021 Feb; 203(4):525-526. PubMed ID: 33105086
[No Abstract] [Full Text] [Related]
5. Assessing the cancer hypothesis of pulmonary arterial hypertension: the devil is in the detail.
Frump AL; Lai YC; Lahm T
Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1140-L1141. PubMed ID: 32186392
[No Abstract] [Full Text] [Related]
6. Multilevel omics: A next step on the way to understanding pulmonary arterial hypertension?
Aman J; Hovingh GK
Thorax; 2019 Apr; 74(4):317-318. PubMed ID: 30679265
[No Abstract] [Full Text] [Related]
7. Deconstructing the Melting Pot in Pulmonary Arterial Hypertension.
Austin ED; Hamid R
Am J Respir Crit Care Med; 2020 Jun; 201(11):1329-1331. PubMed ID: 32053755
[No Abstract] [Full Text] [Related]
8. Checkpoint Kinase 1 Promotes the Development of Pulmonary Arterial Hypertension.
Satoh K; Kikuchi N; Kurosawa R; Shimokawa H
Arterioscler Thromb Vasc Biol; 2019 Aug; 39(8):1504-1506. PubMed ID: 31339778
[No Abstract] [Full Text] [Related]
9. "Rehab for all!" Is it too early in pulmonary arterial hypertension?
Bertoletti L; Bouvaist H; Tromeur C; Bezzeghoud S; Dauphin C; Enache I; Bourdin A; Seronde MF; Montani D; Turquier S; Pison C; ;
Eur Respir J; 2019 Nov; 54(5):. PubMed ID: 31699779
[No Abstract] [Full Text] [Related]
10. A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension.
Grinnan D; Farkas L
Am J Respir Crit Care Med; 2019 Jun; 199(12):1460-1461. PubMed ID: 30973752
[No Abstract] [Full Text] [Related]
11. Real-World Data for Pulmonary Arterial Hypertension.
Elliott CG
Chest; 2019 Apr; 155(4):653-654. PubMed ID: 30955564
[No Abstract] [Full Text] [Related]
12. [Diagnosis of idiopathic pulmonary arterial hypertension by "3P" algorithm].
Fan FL; Zhang SL; Song Q; Xie XG; Zhang YP; Huo XW; Zou YL
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):621-625. PubMed ID: 32842275
[TBL] [Abstract][Full Text] [Related]
13. Request to "Update" the 2019 Update of Guidelines for Management of Pulmonary Arterial Hypertension.
Durrani J; Toor A
Chest; 2019 Jul; 156(1):187. PubMed ID: 31279369
[No Abstract] [Full Text] [Related]
14. The Janus Faces of Bone Morphogenetic Protein 9 in Pulmonary Arterial Hypertension.
Ormiston ML; Godoy RS; Chaudhary KR; Stewart DJ
Circ Res; 2019 Mar; 124(6):822-824. PubMed ID: 30870124
[No Abstract] [Full Text] [Related]
15. Still puzzling about a clear definition of pulmonary arterial hypertension in newborns.
Calcaterra G; Fanos V; Bassareo PP
Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30923176
[No Abstract] [Full Text] [Related]
16. EpiHope for the Treatment of Pulmonary Arterial Hypertension: Selective versus Nonselective BET Inhibition.
Pullamsetti SS; de Jesus Perez VA
Am J Respir Crit Care Med; 2019 Nov; 200(9):1188-1190. PubMed ID: 31419389
[No Abstract] [Full Text] [Related]
17. Protease-activated receptor 1 as potential therapeutic target in pulmonary arterial hypertension.
Merkus D; van Beusekom HMM; Boomars KA
Cardiovasc Res; 2019 Jul; 115(8):1260-1261. PubMed ID: 30903137
[No Abstract] [Full Text] [Related]
18. Response: Still puzzling about a clear definition of pulmonary arterial hypertension in newborns.
Rosenzweig EB; Abman SH; Berger RMF
Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30923178
[No Abstract] [Full Text] [Related]
19. Pulmonary Hypertension Associated With Respiratory Diseases - Which Patients Should Be Treated With Pulmonary Arterial Hypertension-Targeted Therapies?
Sakamaki F; Asano K
Circ J; 2021 Mar; 85(4):343-344. PubMed ID: 33563867
[No Abstract] [Full Text] [Related]
20. Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension.
Declercq M; Treps L; Bousfia S; Carmeliet P; Witters P
Eur Respir J; 2021 Aug; 58(2):. PubMed ID: 34385264
[No Abstract] [Full Text] [Related]
[Next] [New Search]
